ALLOGENE THERAPEUTICS INC. - COMMON STOCK

1.4200

21-April-25 16:45:00

15 minutes delayed

Stocks

-0.0300

-2.07%

Today's range

1.3900 - 1.4900

ISIN

N/A

Source

NASDAQ

Allogene Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Update

25 Feb 2021 16:02:00 By Nasdaq GlobeNewswire
Allogene Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

18 Feb 2021 08:30:00 By Nasdaq GlobeNewswire
Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences

09 Feb 2021 08:30:00 By Nasdaq GlobeNewswire
Allogene Therapeutics Announces Ton Schumacher, Ph.D., Chair of Scientific Advisory Board, Awarded the 2021 Jeantet-Collen Prize for Translational Medicine

26 Jan 2021 08:30:00 By Nasdaq GlobeNewswire
Allogene Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference

05 Jan 2021 08:30:00 By Nasdaq GlobeNewswire

<<
<
4
5
6
7
8
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.